Close Menu
Home » Exome Sequencing Study Narrows in on New Cushing's Syndrome Gene Culprit

Exome Sequencing Study Narrows in on New Cushing's Syndrome Gene Culprit

Feb 28, 2014
|
staff reporter

NEW YORK (GenomeWeb News) – In a study published online this week in the New England Journal of Medicine, an international team described new mutations involved in a severe form of Cushing's syndrome caused by adrenal adenoma tumors or overgrowths rather than excess pituitary gland activity.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

GEDmatch Under New Owners

Forensic genetic firm Verogen has bought the genetic genealogy site GEDmatch.

Generations of Bunnies

Researchers have 3D-printed plastic bunnies that encase the information needed to make more such bunnies in DNA, according to Discover magazine.

To Inform the Discussion

Dan Rather, the former CBS Evening News anchor and executive producer of a new documentary, writes at the Guardian that everyone needs to know about CRISPR.

PNAS Studies on ER+ Breast Cancer Target, Skin Condition Gene Repair, Uveoretinitis

In PNAS this week: analysis of FOXA1 upregulation in ER-positive breast cancer, gene editing to correct recessive dystrophic epidermolysis bullosa, and more.

Dec
17
Featured Webinar

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

What's Popular?

In Clinical Sequencing

  1. Adaptive Biotechnologies, AbbVie Partner on MRD Testing in Multiple Myeloma Drug Trials

  2. ASH Study: Germline Testing Identifies Cancer Risk Mutations, VUS in Older AML Patients

  3. Gene Panel Finds Pathogenic Variants Missed by Standard Tests in 5 Percent of Familial Cancer Cases

  4. Childhood Kidney Cancer Arises From Altered Normal Tissue, Sequencing Study Finds

  5. Enpicom, Cytura Therapeutics to Develop Cancer Diagnostic

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.